Effect of Dolutegravir on adrenal function in HIV patients on ARVs using serum and salivary cortisol assay

2021 ◽  
Author(s):  
Mansur Ramalan ◽  
Ibrahim Gezawa ◽  
Musa Babamaiyaki ◽  
Musa Babashani ◽  
Mukthar Aliyu
Author(s):  
Rajan S. Patel ◽  
Steve R. Shaw ◽  
Halena MacIntyre ◽  
Gerald W. McGarry ◽  
A. Michael Wallace

AbstractBackground: Salivary cortisol concentrations correlate well with biologically active unbound free plasma cortisol concentrations. Despite its practical and analytical advantages, salivary cortisol measurement has been used mainly as a research tool rather than for the routine evaluation of adrenal function. This may be partly explained by the lack of robust reference data in the literature.Methods: Using the recommended procedures for the production of reference intervals published by the International Federation of Clinical Chemistry, we aimed to produce morning salivary cortisol reference intervals for males and females. Salivary cortisol was measured in 496 specimens collected from 248 reference individuals (128 males, median age 41years, range 16–86; and 120 females, median age 44years, range 16–98) attending an otorhinolaryngology clinic. Reference individuals mailed saliva specimens sampled on two consecutive mornings to our laboratory, where cortisol concentrations were measured.Results: Statistical analysis showed no significant correlation with age or body mass index. The following 95% gender-partitioned reference intervals were produced: males 10.9–40.3nmol/l; and females 9.3–40.3nmol/l.Conclusion: Knowledge of these salivary cortisol reference intervals helps us monitor the adrenal function of outpatients using topical intranasal glucocorticoids for rhinosinusitis.


1988 ◽  
Vol 66 (2) ◽  
pp. 343-348 ◽  
Author(s):  
M. H. LAUDAT ◽  
S. CERDAS ◽  
C. FOURNIER ◽  
D. GUIBAN ◽  
B. GUILHAUME ◽  
...  

2010 ◽  
Vol 52 (6) ◽  
pp. 839-845 ◽  
Author(s):  
Arnaud Galbois ◽  
Marika Rudler ◽  
Julien Massard ◽  
Yvonne Fulla ◽  
Abdelhai Bennani ◽  
...  

1988 ◽  
Vol 23 (4) ◽  
pp. 335-349 ◽  
Author(s):  
Jean-Pierre Kahn ◽  
David R. Rubinow ◽  
Candace L. Davis ◽  
Mitchell Kling ◽  
Robert M. Post

2021 ◽  
Vol 5 (1) ◽  
pp. 024-028
Author(s):  
Capdevila Laura ◽  
Borràs Ariadna ◽  
Berlanga Eugenio ◽  
Sánchez-Manubens Judith ◽  
Rivera Josefa ◽  
...  

Background: The main cause of adrenal insufficiency (AI) in paediatric patients is prolonged treatment with corticosteroids. Determination of plasma cortisol (PC) during ACTH test is the most used adrenal function indicator in clinical practice. However, determination of salivary cortisol (SC), a simple test especially useful in children in order to avoid invasive procedures, can be used as an alternative technique for the diagnosis of adrenal disease. Methods: A two-year prospective study (January 2014-January 2016) in paediatric patients (2-18 years of age) treated with corticosteroids for more than fifteen days, who were investigated for suspected AI. Low-dose ACTH test was used to determine adrenal function and samples for SC and PC were obtained simultaneously in basal situation and during the test (at 30, 60 and 90 minutes). Results: 230 samples (118 PC-112 SC) of 30 studies belonging to 20 patients (4 males), mean age 10.93 years ± 3.69 SD. Pearson’s correlation coefficient showed a positive correlation between PC and SC (r = 0.618, p < 0.001). All the studies with some determination of PC higher than 18 μg/dL (n = 8) had a SC peak higher than 0.61 μg/dL with a specificity of 66.67% and a sensitivity of 93.94% (ROC analysis). Conclusion: Measurement of SC is a less invasive, easier and quicker test than PC to measure plasma free cortisol levels. In our study, a SC peak in low-dose ACTH test higher than 0.61 μg/dL was able to discriminate patients without AI, and proved to be a useful tool in the initial evaluation of children with suspected AI.


1988 ◽  
Vol 24 (8) ◽  
pp. 954-955
Author(s):  
B. Harris ◽  
G.F. Read ◽  
R.F. Walker ◽  
D. Riad-Fahmy

2020 ◽  
Vol 9 (10) ◽  
pp. 3233 ◽  
Author(s):  
Katarzyna Pelewicz ◽  
Sebastian Szewczyk ◽  
Piotr Miśkiewicz

Treatment of active, moderate-to-severe Graves’ orbitopathy (GO) is the administration of intravenous methylprednisolone (IVMP). IVMP may be followed by additional therapy with oral prednisone. The aim of this study was to analyze the impact of IVMP on adrenal function by evaluation of serum, salivary cortisol and serum dehydroepiandrosterone sulfate (DHEA-S). Fourteen patients received IVMP treatment (cumulative dose of 4.5 g in 12 weekly infusions) followed by oral prednisone (for three months). All patients showed normal adrenal function before the 12th IVMP pulse and one patient was diagnosed with secondary adrenal insufficiency (AI) after prednisone treatment. DHEA-S was significantly lower before the 12th IVMP pulse and after oral prednisone (p = 0.015 and p = 0.00002, respectively) in comparison to evaluation before therapy. DHEA-S levels were below the reference range in one and three patients before the 12th IVMP pulse and after prednisone therapy, respectively. We observed decreased serum (p = 0.05) and salivary (p = 0.011) cortisol levels after oral prednisone therapy in comparison to evaluation before therapy. Treatment with IVMP in a cumulative dose of 4.5 g affects adrenal function, causing more severe impairment of DHEA-S secretion than that of cortisol but does not cause secondary AI. Additional therapy with oral glucocorticoids after IVMP can cause secondary AI.


Sign in / Sign up

Export Citation Format

Share Document